Articles Posted in Mass Torts

This page is about Gerber baby food autism lawsuits and expected settlement amounts in these claims.

Current research and testing have shown that Gerber and other major brands of baby food contain dangerously high levels of toxic heavy metals such as lead, arsenic, and mercury. These harmful metals cause health complications and neurologic damage in developing children. The development of conditions such as ADHD and autism may be linked to consuming these toxic baby foods.

Our lawyers are taking new cases from children (and their parents) who consumed contaminated Gerber baby foods and were later diagnosed with neurologic health conditions such as autism.

Nitrous oxide cartridges, often sold under names like Whip-Its, Galaxy Gas, and Baking Bad, are now at the center of a growing wave of lawsuits across the country. Our lawyers are handling claims against manufacturers, distributors, and retailers for serious nitrous oxide injuries.

What was marketed as a novelty or culinary product has become a common recreational inhalant, especially among young people. Repeated use is dangerous. It can cause neurological injury, psychiatric damage, spinal cord dysfunction, and in some cases, death. Nitrous oxide use is now showing up in medical records, emergency rooms, and court filings. This is a serious and escalating problem.

Lawsuits allege that companies failed to warn about known risks, marketed products in ways that encouraged abuse, and ignored clear signs of harm. Cases include personal injury and wrongful death claims, as well as proposed class actions arising from deceptive labeling and distribution practices. These claims could eventually be consolidated in a federal MDL for coordinated pretrial proceedings.

Video game addiction lawsuits are gaining momentum as families and individuals come forward to seek accountability from gaming companies for the harm caused by gaming addiction. These cases focus on holding video game manufacturers accountable for exploiting vulnerable players, particularly minors and young adults, through intentionally addictive game designs. Gaming addiction has caused significant harm, including mental health struggles, social isolation, and financial strain, as companies prioritize profit over user safety.

Our attorneys examine the rise of video game addiction lawsuits and delve into key aspects such as the alleged failure to warn and the intentional design defects that make games like Fortnite, Roblox, Minecraft, and Call of Duty so addictive.

While these lawsuits are still in their early stages, we focus on the heart of these cases: the significant injuries sustained by individuals and the potential settlement payouts, as financial compensation is central to resolving these civil claims. Below, we also explore updates on specific lawsuits, recent litigation trends, and eligibility criteria for filing a video game addiction lawsuit. We also look at the potential settlement value of these lawsuits if they play out as our lawyers expect.

Dupixent (dupilumab) is a biologic medication used to treat atopic dermatitis, asthma, and other inflammatory conditions. It works by targeting specific immune pathways involved in allergic inflammation. For many patients with moderate to severe eczema, Dupixent has provided relief where topical medications failed. As a result, it has become one of the most widely prescribed biologic drugs for skin and respiratory conditions.

But for a growing number of patients, the experience with Dupixent has been very different. Over the past several years, doctors and researchers have reported cases in which patients treated with Dupixent were later diagnosed with cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma that primarily affects the skin. These reports have led to increasing scrutiny of whether Dupixent can worsen, accelerate, or mask CTCL in certain patients.

Lawyers across the country are now reviewing Dupixent lawsuits on behalf of patients who developed CTCL, mycosis fungoides, or Sézary syndrome after receiving Dupixent injections.

The Cartiva toe implant is a synthetic cartilage device used to treat arthritis in the big toe. New evidence suggests that these implants are defectively designed and prone to failures that can result in pain, further surgery, and other injuries. Cartiva toe implant lawsuits are now being filed by individuals who experienced a premature failure of their implant.

We hoped to see Cartiva settlement payouts by 2025 as part of a global settlement. That has not happened. Unfortunately, this litigation is dragging on. But these lawsuits could reach a settlement at any time. You want to submit a case before that happens. So, if you have a claim, call us or another lawyer sooner rather than later.

Not many of these lawsuits have been filed.   But there are many more cases out there, and that is likely to change if there is no settlement soon. If you have a potential claim, call us today at 800-553-8082 or get a free consultation online.

Our lawyers handle Paraquat lawsuits in all 50 states. This page provides the latest news and updates on Paraquat lawsuits in both state and federal courts. We also give our perspective on where this litigation is heading and provide projected settlement payouts for a viable Paraquat lawsuit. Continue reading

Our attorneys also provide the latest updates from the Zantac class action lawsuit (including the disastrous news of the class action judge dismissing all of the federal court Zantac lawsuits. This page was updated on August 13, 2025.

Zantac Cancer Lawsuit Updates 2025

The Zantac litigation has been a rollercoaster, filled with major victories, setbacks, and unexpected twists. From the initial discovery of NDMA contamination to the collapse of certain cases and the resurgence of others, this litigation has taken many turns.

Our law firm  was handling Philips CPAP machine lawsuits for injuries from the recalled Philips CPAP machine.

The Philips recall covered an estimated 3.5 million sleep apnea devices. A CPAP class action lawsuit with thousands of plaintiffs has been consolidated into a multi-district litigation (MDL-1230). So, every Philips CPAP lawsuit in federal court—filed in New York, California, Texas, or wherever—was consolidated in federal court in Pennsylvania.

After the settlement, we are no longer reviewing new cases.

Tylenol autism lawsuits are being filed nationwide with a new Tylenol Autism class action lawsuit – technically an MDL, as we explain below – now certified in federal court. But, as we discuss below, that MDL is on the thinnest of ice although we do not know what the latest support from the government might do.

We encourage parents interested in bringing a Tylenol lawsuit to consider filing a toxic baby food lawsuit

Update: The federal court cases are dismissed. There is an appeal. See the updates below, which discuss your options moving forward. There is also some hope for optimism based on recent events discussed below.

For sickle cell patients and families, Oxbryta was supposed to be a lifeline. Instead, it left many worse off–facing new health crises, hospitalizations, and in some cases, unthinkable loss. Now, Oxbryta lawsuits are uncovering what Pfizer knew and when it knew it.

Oxbryta is a prescription drug developed by Global Blood Therapeutics and later acquired by Pfizer. It was voluntarily recalled in September 2024 after new evidence revealed that it caused serious and potentially fatal complications, including vaso-occlusive crises and organ damage.

This page looks at Oxbryta lawsuits and their potential settlement value.

Oxbryta is a prescription drug made by Pfizer that was recalled in September 2024 after evidence revealed that it caused a number of very serious and potentially fatal health problems, including vaso-occlusive crisis and organ damage. Continue reading